US Stock MarketDetailed Quotes

HUGE FSD Pharma

Watchlist
  • 0.0899
  • 0.00000.00%
Close Aug 14 16:00 ET
6.98MMarket Cap-5P/E (TTM)

FSD Pharma Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-75.77%2.25M
-28.65%19.57M
-71.45%1.9M
-54.35%3.31M
-25.89%5.46M
57.63%9.3M
-18.71%27.43M
8.84%6.66M
41.33%7.25M
-41.92%7.37M
Selling and administrative expenses
-66.32%1.97M
-17.37%13.2M
-35.55%1.81M
-24.60%3.2M
-43.13%2.74M
51.71%5.86M
-31.62%15.98M
-32.51%2.81M
0.14%4.24M
-40.39%4.83M
-General and administrative expense
-66.32%1.97M
-17.37%13.2M
-35.55%1.81M
-24.60%3.2M
-43.13%2.74M
51.71%5.86M
-31.62%15.98M
-32.51%2.81M
0.14%4.24M
-40.39%4.83M
Research and development costs
-93.07%160.26K
-44.16%3.86M
-101.11%-29.96K
-101.77%-32.99K
14.05%1.61M
146.69%2.31M
9.21%6.91M
216.16%2.69M
1,840.41%1.87M
-60.91%1.41M
Depreciation amortization depletion
-89.37%120.14K
-44.76%2.51M
-89.44%122.22K
-87.19%146.81K
-2.21%1.11M
2.62%1.13M
12.16%4.54M
4.54%1.16M
14.08%1.15M
15.27%1.13M
-Depreciation and amortization
-89.37%120.14K
-44.76%2.51M
-89.44%122.22K
-87.19%146.81K
-2.21%1.11M
2.62%1.13M
12.16%4.54M
4.54%1.16M
14.08%1.15M
15.27%1.13M
Operating profit
75.77%-2.25M
28.65%-19.57M
71.45%-1.9M
54.35%-3.31M
25.89%-5.46M
-57.63%-9.3M
18.71%-27.43M
-8.84%-6.66M
-41.33%-7.25M
41.92%-7.37M
Net non-operating interest income expense
-41.07%160.11K
146.48%786.06K
-48.72%153.78K
252.80%174.45K
1,426.42%186.16K
1,758.37%271.67K
568.22%318.91K
1,126.82%299.88K
2,626.67%49.45K
25.81%-14.04K
Non-operating interest income
-36.65%172.52K
113.84%786.36K
-48.74%153.79K
165.76%174.07K
8,293.28%186.16K
--272.34K
28,362.46%367.74K
--300.02K
--65.5K
--2.22K
Non-operating interest expense
1,761.17%12.41K
-99.39%299
-91.11%12
----
--0
-95.93%667
-29.66%48.82K
-99.54%135
720.24%16.05K
-14.08%16.25K
Total other finance cost
----
----
----
---380
----
----
----
----
----
----
Other net income (expense)
100.18%1.68K
35.97%553.46K
-54.59%96.02K
2,545.66%2.01M
63.12%-214.5K
-304.58%-930.28K
422.57%407.04K
1,514.39%211.45K
115.79%75.83K
-1,162.54%-581.58K
Gain on sale of security
104.25%19.15K
-40.80%170.25K
56.73%332.2K
-115.19%-5.86K
220.04%698.1K
-221.02%-450.18K
263.42%287.58K
1,517.77%211.96K
108.04%38.6K
-579.36%-581.58K
Special income (charges)
96.36%-17.48K
---4.56M
---236.19K
--0
---3.84M
---480.1K
--0
--0
--0
--0
-Less:Impairment of capital assets
----
--4.56M
--236.19K
--0
--3.84M
----
--0
--0
--0
--0
-Less:Other special charges
--17.48K
----
----
----
----
----
----
----
----
----
-Write off
--0
----
----
----
----
--480.1K
----
----
----
----
Other non- operating income (expenses)
----
4,034.69%4.94M
--0
5,303.91%2.01M
--2.93M
----
139.90%119.45K
---506
--37.23K
----
Income before tax
79.00%-2.09M
31.73%-18.23M
73.14%-1.65M
84.13%-1.13M
31.07%-5.49M
-82.34%-9.96M
21.32%-26.7M
0.24%-6.15M
-26.97%-7.13M
37.55%-7.97M
Income tax
Net income
79.00%-2.09M
22.77%-18.23M
73.14%-1.65M
84.13%-1.13M
-24.10%-5.49M
-68.62%-9.96M
33.10%-23.61M
3.14%-6.15M
-23.10%-7.13M
66.50%-4.42M
Net income continuous Operations
79.00%-2.09M
31.73%-18.23M
73.14%-1.65M
84.13%-1.13M
31.07%-5.49M
-82.34%-9.96M
21.32%-26.7M
0.24%-6.15M
-26.97%-7.13M
37.55%-7.97M
Net income discontinuous operations
----
--0
--0
--0
--0
----
329.83%3.1M
--0
--0
881.86%3.54M
Minority interest income
-188.05K
-328.41K
0
0
Net income attributable to the parent company
80.89%-1.9M
24.17%-17.9M
78.48%-1.32M
84.13%-1.13M
-24.10%-5.49M
-68.62%-9.96M
33.10%-23.61M
3.14%-6.15M
-23.10%-7.13M
66.50%-4.42M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
80.89%-1.9M
24.17%-17.9M
78.48%-1.32M
84.13%-1.13M
-24.10%-5.49M
-68.62%-9.96M
33.10%-23.61M
3.14%-6.15M
-23.10%-7.13M
66.50%-4.42M
Basic earnings per share
80.77%-3.25
24.59%-29.9
75.00%-2.6
84.21%-1.95
-16.67%-9.1
-73.33%-16.9
39.60%-39.65
-23.08%-10.4
-26.67%-12.35
66.67%-7.8
Diluted earnings per share
80.77%-3.25
24.59%-29.9
75.00%-2.6
84.21%-1.95
-16.67%-9.1
-73.33%-16.9
39.60%-39.65
-23.08%-10.4
-26.67%-12.35
66.67%-7.8
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -75.77%2.25M-28.65%19.57M-71.45%1.9M-54.35%3.31M-25.89%5.46M57.63%9.3M-18.71%27.43M8.84%6.66M41.33%7.25M-41.92%7.37M
Selling and administrative expenses -66.32%1.97M-17.37%13.2M-35.55%1.81M-24.60%3.2M-43.13%2.74M51.71%5.86M-31.62%15.98M-32.51%2.81M0.14%4.24M-40.39%4.83M
-General and administrative expense -66.32%1.97M-17.37%13.2M-35.55%1.81M-24.60%3.2M-43.13%2.74M51.71%5.86M-31.62%15.98M-32.51%2.81M0.14%4.24M-40.39%4.83M
Research and development costs -93.07%160.26K-44.16%3.86M-101.11%-29.96K-101.77%-32.99K14.05%1.61M146.69%2.31M9.21%6.91M216.16%2.69M1,840.41%1.87M-60.91%1.41M
Depreciation amortization depletion -89.37%120.14K-44.76%2.51M-89.44%122.22K-87.19%146.81K-2.21%1.11M2.62%1.13M12.16%4.54M4.54%1.16M14.08%1.15M15.27%1.13M
-Depreciation and amortization -89.37%120.14K-44.76%2.51M-89.44%122.22K-87.19%146.81K-2.21%1.11M2.62%1.13M12.16%4.54M4.54%1.16M14.08%1.15M15.27%1.13M
Operating profit 75.77%-2.25M28.65%-19.57M71.45%-1.9M54.35%-3.31M25.89%-5.46M-57.63%-9.3M18.71%-27.43M-8.84%-6.66M-41.33%-7.25M41.92%-7.37M
Net non-operating interest income expense -41.07%160.11K146.48%786.06K-48.72%153.78K252.80%174.45K1,426.42%186.16K1,758.37%271.67K568.22%318.91K1,126.82%299.88K2,626.67%49.45K25.81%-14.04K
Non-operating interest income -36.65%172.52K113.84%786.36K-48.74%153.79K165.76%174.07K8,293.28%186.16K--272.34K28,362.46%367.74K--300.02K--65.5K--2.22K
Non-operating interest expense 1,761.17%12.41K-99.39%299-91.11%12------0-95.93%667-29.66%48.82K-99.54%135720.24%16.05K-14.08%16.25K
Total other finance cost ---------------380------------------------
Other net income (expense) 100.18%1.68K35.97%553.46K-54.59%96.02K2,545.66%2.01M63.12%-214.5K-304.58%-930.28K422.57%407.04K1,514.39%211.45K115.79%75.83K-1,162.54%-581.58K
Gain on sale of security 104.25%19.15K-40.80%170.25K56.73%332.2K-115.19%-5.86K220.04%698.1K-221.02%-450.18K263.42%287.58K1,517.77%211.96K108.04%38.6K-579.36%-581.58K
Special income (charges) 96.36%-17.48K---4.56M---236.19K--0---3.84M---480.1K--0--0--0--0
-Less:Impairment of capital assets ------4.56M--236.19K--0--3.84M------0--0--0--0
-Less:Other special charges --17.48K------------------------------------
-Write off --0------------------480.1K----------------
Other non- operating income (expenses) ----4,034.69%4.94M--05,303.91%2.01M--2.93M----139.90%119.45K---506--37.23K----
Income before tax 79.00%-2.09M31.73%-18.23M73.14%-1.65M84.13%-1.13M31.07%-5.49M-82.34%-9.96M21.32%-26.7M0.24%-6.15M-26.97%-7.13M37.55%-7.97M
Income tax
Net income 79.00%-2.09M22.77%-18.23M73.14%-1.65M84.13%-1.13M-24.10%-5.49M-68.62%-9.96M33.10%-23.61M3.14%-6.15M-23.10%-7.13M66.50%-4.42M
Net income continuous Operations 79.00%-2.09M31.73%-18.23M73.14%-1.65M84.13%-1.13M31.07%-5.49M-82.34%-9.96M21.32%-26.7M0.24%-6.15M-26.97%-7.13M37.55%-7.97M
Net income discontinuous operations ------0--0--0--0----329.83%3.1M--0--0881.86%3.54M
Minority interest income -188.05K-328.41K00
Net income attributable to the parent company 80.89%-1.9M24.17%-17.9M78.48%-1.32M84.13%-1.13M-24.10%-5.49M-68.62%-9.96M33.10%-23.61M3.14%-6.15M-23.10%-7.13M66.50%-4.42M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 80.89%-1.9M24.17%-17.9M78.48%-1.32M84.13%-1.13M-24.10%-5.49M-68.62%-9.96M33.10%-23.61M3.14%-6.15M-23.10%-7.13M66.50%-4.42M
Basic earnings per share 80.77%-3.2524.59%-29.975.00%-2.684.21%-1.95-16.67%-9.1-73.33%-16.939.60%-39.65-23.08%-10.4-26.67%-12.3566.67%-7.8
Diluted earnings per share 80.77%-3.2524.59%-29.975.00%-2.684.21%-1.95-16.67%-9.1-73.33%-16.939.60%-39.65-23.08%-10.4-26.67%-12.3566.67%-7.8
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg